{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:03:06Z","timestamp":1785769386885,"version":"3.56.0"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Histiocytic sarcoma (HS) is a rare and aggressive hematologic malignancy with a poor prognosis. HS can present with either isolated organ involvement or multi-systemic disease. This case series reports on nine patients with diverse clinical presentations and outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Diagnoses of HS were confirmed using immunohistochemistry, with markers such as CD68 and lysozyme. Treatment primarily involved anthracycline-based chemotherapy with autologous hematopoietic stem cell transplantation (auto-HSCT) consolidation, and with salvage therapies for resistant or relapsed cases including allogeneic HSCT (allo-HSCT).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Despite intensive treatment, long-term remission was rare. Among the nine patients, three achieved complete remission but relapsed, three had stable disease, two experienced progressive disease, and one is under treatment. No patient maintained complete remission for at least three years, indicating the chemo-resistant nature of HS. Moreover, of three cases in our cohort that achieved complete remission, two declined auto-HSCT owing to the intensity of first-line chemotherapy, and one relapsed shortly after achieving remission. To overcome chemo-resistance, four patients underwent allo-HSCT, and two of them achieved long-term remission.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These findings highlight the importance of early diagnosis and suggest potential benefits of either autologous or allogeneic transplantation, while emphasizing the need for further research on treatment protocols.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1505737","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:10:49Z","timestamp":1740373849000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Case Report: A case series on histiocytic sarcoma \u2013 various clinical features and patient outcomes"],"prefix":"10.3389","volume":"15","author":[{"given":"Hohyung","family":"Nam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi-June","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong Yoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngwoo","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Goo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.47.0386","article-title":"Histiocytic sarcoma: identification of its histiocytic origin using immunohistochemistry","volume":"47","author":"Yoshida","year":"2008","journal-title":"Intern Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s44313-024-00015-9","article-title":"Pathologic characteristics of histiocytic and dendritic cell neoplasms","volume":"59","author":"Yoon","year":"2024","journal-title":"Blood Res"},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.36255\/exon-publications-leukemia-who-5th-edition-hematolymphoid-tumors","article-title":"Chapter 1 The 5th Edition of the world health organization classification of hematolymphoid tumors","volume-title":"Leukemia","author":"Li","year":"2022"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2559.2002.01418.x","article-title":"Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases","volume":"41","author":"Pileri","year":"2002","journal-title":"Histopathology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-10-812495","article-title":"Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes","volume":"131","author":"Kommalapati","year":"2018","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1492128","article-title":"Predictors of survival, treatment patterns, and outcomes in histiocytic sarcoma","volume":"60","author":"Kommalapati","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"B7","doi-asserted-by":"publisher","first-page":"17496","DOI":"10.1038\/s41598-023-44241-0","article-title":"The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed\/refractory diffuse large B cell lymphoma","volume":"13","author":"Min","year":"2023","journal-title":"Sci Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3960\/jslrt.53.1","article-title":"Histiocytic sarcoma: an updated literature review based on the 2008 WHO classification","volume":"53","author":"Takahashi","year":"2013","journal-title":"J Clin Exp Hematop"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000131541.95394.23","article-title":"Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid Malignancy","volume":"28","author":"Hornick","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2020.01.002","article-title":"Histiocytic sarcoma of the base of tongue treated with radical radiotherapy: A case report and review of the literature","volume":"21","author":"Iyizoba-Ebozue","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3747\/co.19.964","article-title":"Long-term remission after autologous stem-cell transplantation for relapsed histiocytic sarcoma","volume":"19","author":"Abu-Sanad","year":"2012","journal-title":"Curr Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-014-1630-y","article-title":"Successful treatment of histiocytic sarcoma with induction chemotherapy consisting of dose-escalated CHOP plus etoposide and upfront consolidation auto-transplantation","volume":"100","author":"Tsujimura","year":"2014","journal-title":"Int J Hematol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.6603","article-title":"Autologous hematopoietic stem-cell transplantation in combination with thalidomide as treatment for histiocytic sarcoma: a case report and review of the literature","volume":"29","author":"Gergis","year":"2011","journal-title":"J Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/728260","article-title":"Successful treatment of multifocal histiocytic sarcoma occurring after renal transplantation with cladribine, high-dose cytarabine, G-CSF, and mitoxantrone (CLAG-M) followed by allogeneic hematopoietic stem cell transplantation","volume":"2015","author":"Tomlin","year":"2015","journal-title":"Case Rep Hematol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.36401\/JIPO-23-11","article-title":"Histiocytic sarcoma treated with pembrolizumab: A case report and literature review","volume":"6","author":"Huff","year":"2023","journal-title":"J Immunother Precis Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1505737\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:10:53Z","timestamp":1740373853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1505737\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":16,"alternative-id":["10.3389\/fonc.2025.1505737"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1505737","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"article-number":"1505737"}}